Identification of Laylaa 21:

No description

Search images on Google      Product Monograph

Active Ingredients:

• levonorgestrel, 0.1 MG
• ethinyl estradiol, 0.02 MG

DIN: 02424282

Dosage Form(s): TABLET

Route(s) of Administration: ORAL

Description: 21 DAYS

Schedule: Prescription

Company: LUPIN PHARMA CANADA LIMITED

ATC:

• G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, WHO, Wiki)
• G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, WHO)
• G03AA - Progestogens and estrogens, fixed combinations (ATC, WHO)
• G03AA07 - LEVONORGESTREL AND ESTROGEN (WHO)

Pharmaceutical standard: MFR

 

External Links for Laylaa 21:

Search on Google

• Laylaa 21 side effects
• Laylaa 21 dosage
• levonorgestrel side effects
• levonorgestrel dosage
• ethinyl estradiol side effects
• ethinyl estradiol dosage